HQY Maintained by Barclays -- Price Target Raised to $115

gurufocus.com · 2026-09-18

HealthEquity (HQY) Analyst Rating Update On September 18, 2026, Barclays maintained an "Overweight" rating for HealthEquity (HQY). The price target has been

TickrTrends take: Barclays raised its price target for HQY to $115, signaling confidence in the company's fundamentals within the Healthcare sector. This target increase aligns with TickrTrends' current assessment that the stock is undervalued, suggesting potential upside for investors monitoring the gap between current trading levels and analyst expectations. A valuation-focused reader should track whether the stock approaches the $115 target and whether additional analyst upgrades follow, as these could indicate the market is repricing HQY toward its intrinsic value.

Read the full story at gurufocus.com →